Editas Medicine Presents Pre-Clinical Data Supporting the use of CRISPR-Cas12a to Edit Induced …,

… a leading genome editing company, today announced results from a pre-clinical study evaluating multi-gene knockout and transgene knock-in using …, … a leading genome editing company, today announced results from a pre-clinical study evaluating multi-gene knockout and transgene knock-in using …, Read More

Scroll to Top